ABEO,Abeona Therapeutics Inc. | Healthcare

Healthcare

ABEO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Abeona Therapeutics Inc.ABEO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa.

The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy.

In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015.

Abeona Therapeutics Inc. is headquartered in New York, New York.

Latest News >

Here's How Much $100 Invested In Guidewire Software 10 Years Ago Would Be Worth Today

Dec 23, 2024

Guidewire Software ( GWRE ) has outperformed the market over the past 10 years by 1.8% on an annualized basis producing an average annual return of 12.9%. Currently, Guidewire Software ( GWRE ) has a market capitalization of $14.36 billion. Buying $100 In GWRE: If an investor had bought $100 of GWRE stock 10 years ago, it would be worth...

Rayonier Unveils Alabama Deal With Affiliate of Reliant Carbon Capture & Storage

Dec 23, 2024

05:02 PM EST, 12/23/2024 (MT Newswires) -- Rayonier ( RYN ) disclosed late Monday an agreement with Reliant Carbon Capture & Storage affiliate covering about 104,000 acres in Alabama. The company did not disclose the financial details of the underground pore space easement agreement. Reliant captures carbon dioxide emissions from power plants and industrial facilities and sequesters it in subsurface...

Construction Partners Insider Sold Shares Worth $504,110, According to a Recent SEC Filing

Dec 23, 2024

04:57 PM EST, 12/23/2024 (MT Newswires) -- Todd Keith Andrews, Chief Accounting Officer, on December 20, 2024, sold 5,489 shares in Construction Partners ( ROAD ) for $504,110. Following the Form 4 filing with the SEC, Andrews has control over a total of 17,394 shares of the company, with 17,394 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1718227/000171822724000138/xslF345X05/wk-form4_1734990749.xml ...

GLOBAL MARKETS-Stocks gain with bond yields, dollar up; economy, rates in focus

Dec 23, 2024

* Dollar gains, with Treasury yields * Global stock index up, Wall St indexes close higher * Consumer confidence comes in light, capital goods rise (Updates after U.S. stock market close) By Sinéad Carew and Amanda Cooper NEW YORK/LONDON, Dec 23 (Reuters) - A global equity index rose on Monday with help from Wall Street, and U.S. Treasury yields climbed...